12 First Eagle Investments Bio-Rad Laboratories Trades
First Eagle Investments's position in Bio-Rad Laboratories is currently worth $766M. That's 1.27% of their equity portfolio (31st largest holding). The investor owns 9.07% of the outstanding Bio-Rad Laboratories stock. The stake costed the investor $718M, netting the investor a gain of 6.8% so far.
Avg closing price
Price range
Increased shares by 1.3% (+32.3k shares)
Q1 2026
Avg closing price
$290.31
Price range
$256.55
-
$325.50
Increased shares by 2.0% (+50.2k shares)
Q4 2025
Avg closing price
$312.28
Price range
$294.24
-
$339.75
Increased shares by 0.1% (+3.01k shares)
Q3 2025
Avg closing price
$272.21
Price range
$241.95
-
$303.82
Increased shares by 60.7% (+951k shares)
Q2 2025
Avg closing price
$236.19
Price range
$216.56
-
$256.68
Increased shares by 119.5% (+853k shares)
Q1 2025
Avg closing price
$301.86
Price range
$243.00
-
$366.66
Increased shares by 0.1% (+505 shares)
Q4 2024
Avg closing price
$339.22
Price range
$313.10
-
$374.01
Increased shares by 12.1% (+76.7k shares)
Q3 2024
Avg closing price
$317.17
Price range
$263.97
-
$344.60
Increased shares by 32296.9% (+634k shares)
Q2 2024
Avg closing price
$290.85
Price range
$268.26
-
$339.48
Increased shares by 310.0% (+1.49k shares)
Q1 2024
Avg closing price
$328.84
Price range
$304.11
-
$351.99
Increased shares by 4.6% (+21 shares)
Q4 2023
Avg closing price
$313.43
Price range
$269.37
-
$365.04
Increased shares by 139.8% (+267 shares)
Q3 2023
Avg closing price
$385.83
Price range
$350.25
-
$422.63
New holding (+191 shares)
Q2 2023
Avg closing price
$406.95
Price range
$359.49
-
$486.40
